Targeted Market Intelligence

In the high-stakes world of oncology and rare diseases, precise insights can mean the difference between a successful strategy and a missed opportunity. Our Targeted Market Intelligence service offers a panoramic view of your specific therapeutic landscape—integrating competitive intelligence, real-world data and patient-centered analysis to support data-driven decisions across the product lifecycle.

Whether you're preparing to launch a novel therapy, navigate complex regulatory environments, or understand unmet patient needs across geographies, we provide the clarity and depth needed to move forward with confidence. Our approach blends quantitative analytics with qualitative insights to decode rapidly evolving markets, uncover hidden demand drivers and inform strategic actions that align with both clinical value and commercial viability.

1 OncoPulse 360

Gain a comprehensive understanding of your market positioning and competitive environment through our advanced market share intelligence.

2 Rare Mosaic

Understand how the market behaves at a granular level with advanced segmentation and modeling capabilities.

3 Launch Sphere RX

Ensure launch success with forward-looking insights into product readiness, competitive response, and market fit.

ONCOPULSE 360

OncoPulse 360 is our proprietary intelligence solution designed specifically for the oncology sector. With it, you gain a holistic, data-driven view of your brand’s market position across multiple therapeutic categories, patient segments and geographies. Our tools track competitor activity, evolving treatment protocols, regulatory changes and emerging players—delivering real-time insights that enable smarter, faster decisions.

Whether you're benchmarking market share, preparing for an investor presentation, or identifying key white spaces, OncoPulse 360 empowers you to make strategic moves with confidence—anchored in data that is relevant, recent, and actionable.

RARE MOSAIC

Rare disease markets are often fragmented, opaque and underserved. RareMosaic helps you make sense of this complexity by offering a detailed, segmented view of your market. From rare cancer subtypes to ultra-rare genetic conditions, we map treatment journeys, highlight unmet clinical needs and dissect prescribing behavior across regions.

Through advanced modeling and dynamic segmentation, RareMosaic allows you to identify high-potential micro-markets, better understand patient and provider needs, and optimize messaging and resource allocation. With predictive analytics and customized dashboards, you can see not just where the market is—but where it's going.

LAUNCH SPHERE RX

In oncology and rare disease markets, product launches are uniquely complex. LaunchSphere RX supports your end-to-end launch strategy with predictive insights and deep planning. We assess your product’s market readiness, competitive environment, pricing dynamics, access challenges and stakeholder expectations—ensuring that every element of your go-to-market plan is rooted in evidence.

From developing your value proposition to anticipating payer objections, LaunchSphere RX helps you refine strategy, mitigate risk and execute with confidence. Whether launching a new molecule, repositioning an orphan drug, or entering a new market, we bring clarity and structure to every stage of the journey.